Literature DB >> 21598389

Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring.

Chor Teck Tan1, Nathan P Croft, Nadine L Dudek, Nicholas A Williamson, Anthony W Purcell.   

Abstract

We describe a cell-free approach that employs selected reaction monitoring (SRM) in tandem mass spectrometry to identify and quantitate T-cell epitopes. This approach utilises multiple epitope-specific SRM transitions to identify known T-cell epitopes and an absolute quantitation (AQUA) peptide strategy to afford AQUA. The advantage of a mass spectrometry-based approach over more traditional cell-based assays resides in the robustness and transferability of an SRM approach between laboratories and the ability of this strategy to detect multiple peptides simultaneously without the requirement of epitope-specific reagents such as T-cell lines. Thus, the SRM strategy for epitope quantitation will find application in studies of antigen density, the link between epitope abundance and immunogenicity, the dynamic range of epitope presentation and the abundance of T-cell epitopes in disease.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Substances:

Year:  2011        PMID: 21598389     DOI: 10.1002/pmic.201000531

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  28 in total

1.  TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.

Authors:  Diego Chowell; Sri Krishna; Pablo D Becker; Clément Cocita; Jack Shu; Xuefang Tan; Philip D Greenberg; Linda S Klavinskis; Joseph N Blattman; Karen S Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

2.  The human leukocyte antigen-presented ligandome of B lymphocytes.

Authors:  Chopie Hassan; Michel G D Kester; Arnoud H de Ru; Pleun Hombrink; Jan Wouter Drijfhout; Harm Nijveen; Jack A M Leunissen; Mirjam H M Heemskerk; J H Frederik Falkenburg; Peter A van Veelen
Journal:  Mol Cell Proteomics       Date:  2013-03-12       Impact factor: 5.911

3.  Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Authors:  Bracha Shraibman; Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Gleb Slobodin; Itzhak Rosner; Carlos López-Larrea; Norbert Hilf; Sabrina Kuttruff; Colette Song; Cedrik Britten; John Castle; Sebastian Kreiter; Katrin Frenzel; Marcos Tatagiba; Ghazaleh Tabatabai; Pierre-Yves Dietrich; Valérie Dutoit; Wolfgang Wick; Michael Platten; Frank Winkler; Andreas von Deimling; Judith Kroep; Juan Sahuquillo; Francisco Martinez-Ricarte; Jordi Rodon; Ulrik Lassen; Christian Ottensmeier; Sjoerd H van der Burg; Per Thor Straten; Hans Skovgaard Poulsen; Berta Ponsati; Hideho Okada; Hans-Georg Rammensee; Ugur Sahin; Harpreet Singh; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2019-06       Impact factor: 5.911

4.  Operational Experience of an Open-Access, Subscription-Based Mass Spectrometry and Proteomics Facility.

Authors:  Nicholas A Williamson
Journal:  J Am Soc Mass Spectrom       Date:  2018-01-03       Impact factor: 3.109

5.  Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes.

Authors:  Jonathan A Trujillo; Stephanie Gras; Kelly-Anne Twist; Nathan P Croft; Rudragouda Channappanavar; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

6.  The cellular redox environment alters antigen presentation.

Authors:  Jonathan A Trujillo; Nathan P Croft; Nadine L Dudek; Rudragouda Channappanavar; Alex Theodossis; Andrew I Webb; Michelle A Dunstone; Patricia T Illing; Noah S Butler; Craig Fett; David C Tscharke; Jamie Rossjohn; Stanley Perlman; Anthony W Purcell
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

7.  The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.

Authors:  Francisco A Chaves; Alvin H Lee; Jennifer L Nayak; Katherine A Richards; Andrea J Sant
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

8.  Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Authors:  Bracha Shraibman; Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Gleb Slobodin; Itzhak Rosner; Carlos López-Larrea; Norbert Hilf; Sabrina Kuttruff; Colette Song; Cedrik Britten; John Castle; Sebastian Kreiter; Katrin Frenzel; Marcos Tatagiba; Ghazaleh Tabatabai; Pierre-Yves Dietrich; Valérie Dutoit; Wolfgang Wick; Michael Platten; Frank Winkler; Andreas von Deimling; Judith Kroep; Juan Sahuquillo; Francisco Martinez-Ricarte; Jordi Rodon; Ulrik Lassen; Christian Ottensmeier; Sjoerd H van der Burg; Per Thor Straten; Hans Skovgaard Poulsen; Berta Ponsati; Hideho Okada; Hans-Georg Rammensee; Ugur Sahin; Harpreet Singh; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2018-08-02       Impact factor: 5.911

Review 9.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

10.  An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments.

Authors:  Martin G Klatt; Zita E H Aretz; Michael Curcio; Ron S Gejman; Heather F Jones; David A Scheinberg
Journal:  J Proteomics       Date:  2020-08-03       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.